{"id":"https://openalex.org/W2322800167","doi":"https://doi.org/10.1097/01.qai.0000456112.75053.a3","title":"F-101 Signaling Pathways and Epigenetic Mechanisms Controlling HIV Latency","display_name":"F-101 Signaling Pathways and Epigenetic Mechanisms Controlling HIV Latency","publication_year":2014,"publication_date":"2014-10-18","ids":{"openalex":"https://openalex.org/W2322800167","doi":"https://doi.org/10.1097/01.qai.0000456112.75053.a3","mag":"2322800167"},"language":"en","primary_location":{"id":"doi:10.1097/01.qai.0000456112.75053.a3","doi":"https://doi.org/10.1097/01.qai.0000456112.75053.a3","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.qai.0000456112.75053.a3","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049581015","display_name":"Jonathan Karn","orcid":"https://orcid.org/0000-0002-2900-094X","observed_orcids":["https://orcid.org/0000-0002-2900-094X"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jonathan Karn","raw_affiliation_strings":["Case Western Reserve University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve University","institution_ids":["https://openalex.org/I58956616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5049581015"],"corresponding_institution_ids":["https://openalex.org/I58956616"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"67","issue":"Supplement 3","first_page":"62","last_page":"62"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-latency","display_name":"HIV-1 latency","score":0.9350000023841858},{"id":"https://openalex.org/keywords/hiv-reservoir","display_name":"HIV reservoir","score":0.5270000100135803},{"id":"https://openalex.org/keywords/epigenetic-silencing","display_name":"epigenetic silencing","score":0.8479999899864197},{"id":"https://openalex.org/keywords/polycomb-repressive-complex-2","display_name":"polycomb repressive complex 2","score":0.9150000214576721},{"id":"https://openalex.org/keywords/ezh2","display_name":"EZH2","score":0.9729999899864197},{"id":"https://openalex.org/keywords/h3k27me3","display_name":"H3K27me3","score":0.9940000176429749},{"id":"https://openalex.org/keywords/p-tefb","display_name":"P-TEFb","score":0.9929999709129333},{"id":"https://openalex.org/keywords/transcription-initiation","display_name":"transcription initiation","score":0.5180000066757202},{"id":"https://openalex.org/keywords/t-cell-receptor-signaling","display_name":"T cell receptor signaling","score":0.7820000052452087},{"id":"https://openalex.org/keywords/th17-cells","display_name":"Th17 cells","score":0.6620000004768372},{"id":"https://openalex.org/keywords/th1-cells","display_name":"Th1 cells","score":0.7630000114440918},{"id":"https://openalex.org/keywords/th2-cells","display_name":"Th2 cells","score":0.8389999866485596},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9739999771118164},{"id":"https://openalex.org/keywords/disulfiram","display_name":"disulfiram","score":0.8050000071525574},{"id":"https://openalex.org/keywords/farnesyltransferase-inhibitors","display_name":"farnesyltransferase inhibitors","score":0.8870000243186951},{"id":"https://openalex.org/keywords/hiv-rebound","display_name":"HIV rebound","score":0.6150000095367432},{"id":"https://openalex.org/keywords/shrna-screen","display_name":"shRNA screen","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7204648852348328},{"id":"https://openalex.org/C179464577","wikidata":"https://www.wikidata.org/wiki/Q1632589","display_name":"Jurkat cells","level":4,"score":0.6369028687477112},{"id":"https://openalex.org/C2776915012","wikidata":"https://www.wikidata.org/wiki/Q17125871","display_name":"PRC2","level":5,"score":0.6203215718269348},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.5647158026695251},{"id":"https://openalex.org/C2778852064","wikidata":"https://www.wikidata.org/wiki/Q4115619","display_name":"Virus latency","level":4,"score":0.5192903876304626},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5111342072486877},{"id":"https://openalex.org/C190232843","wikidata":"https://www.wikidata.org/wiki/Q1950808","display_name":"Small hairpin RNA","level":4,"score":0.4835509955883026},{"id":"https://openalex.org/C2776315342","wikidata":"https://www.wikidata.org/wiki/Q21105865","display_name":"SAMHD1","level":5,"score":0.4544511139392853},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.38596418499946594},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.35162800550460815},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.34017691016197205},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.337779700756073},{"id":"https://openalex.org/C50171091","wikidata":"https://www.wikidata.org/wiki/Q17917770","display_name":"EZH2","level":4,"score":0.32851535081863403},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.32052838802337646},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.25684985518455505},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.2497464418411255},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.18620139360427856},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.1484031081199646},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09631529450416565},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.08795502781867981},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.qai.0000456112.75053.a3","doi":"https://doi.org/10.1097/01.qai.0000456112.75053.a3","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.qai.0000456112.75053.a3","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2895131100","https://openalex.org/W2076340146","https://openalex.org/W2069932442","https://openalex.org/W1990832838","https://openalex.org/W1973694997","https://openalex.org/W2591987892","https://openalex.org/W2061005894","https://openalex.org/W2895555863","https://openalex.org/W2600492502","https://openalex.org/W3042075191"],"abstract_inverted_index":{"Background:":[0],"HAART":[1],"must":[2],"be":[3,259],"continuously":[4],"maintained":[5],"prevent":[6],"HIV-1":[7,19,100],"rebound":[8],"from":[9],"latent":[10,227],"reservoirs.":[11],"Factors":[12],"that":[13,36,160,256],"are":[14],"responsible":[15],"for":[16,167,173],"maintenance":[17,168],"of":[18,32,34,121,149,169,175,196,199,201,215,226,238,252,268],"latency":[20,170],"were":[21,53,62,86,153],"identified":[22,73,119],"by":[23,42,64,74,79,107],"independent":[24],"genome":[25],"wide":[26],"shRNA":[27,50,71],"library":[28,51],"screens.":[29],"The":[30,117,224],"mechanism":[31],"action":[33,200],"compounds":[35],"reactivate":[37],"HIV":[38,176],"proviruses":[39,61,152,177,228],"was":[40,145],"studied":[41],"comparison":[43],"to":[44,110,187,220,244,262],"T-cell":[45,203],"receptor":[46],"activation":[47,214],"pathways.":[48],"Methods:":[49],"screens":[52,182],"performed":[54],"in":[55,155,248],"Jurkat":[56],"T-cells.":[57],"Cells":[58],"carrying":[59],"reactivated":[60],"purified":[63],"sorting":[65],"after":[66],"sequential":[67],"passages":[68],"and":[69,77,92,103,191,209,232,271],"the":[70,122,136,150,156,185,197,202],"sequences":[72],"next-generation":[75],"sequencing":[76],"classified":[78],"systems":[80],"biology":[81],"tools.":[82],"Naive":[83],"T":[84],"cells":[85,141],"polarized":[87],"into":[88,105,178],"Th17,":[89],"Th1,":[90],"Th2,":[91],"Treg":[93],"cells,":[94],"infected":[95,113],"with":[96,125],"a":[97,249],"single":[98],"round":[99],"proviral":[101,221,245,269],"clone":[102],"forced":[104],"quiescence":[106],"cytokine":[108],"restriction":[109],"generate":[111],"latently":[112],"cell":[114],"populations.":[115],"Results:":[116],"screen":[118],"many":[120,260],"shRNAs":[123],"associated":[124],"epigenetic":[126,193],"silencing":[127],"mechanisms,":[128],"as":[129,131],"well":[130],"some":[132],"novel":[133],"targets":[134],"including":[135],"estrogen":[137],"receptor,":[138,204],"ESR1.":[139],"In":[140],"where":[142],"PRC2":[143,161],"(EZH2)":[144],"knocked":[146],"down,":[147],"all":[148],"inducible":[151],"found":[154],"H3K27me3":[157],"population":[158],"suggesting":[159],"complex":[162],"is":[163],"required":[164],"not":[165],"only":[166],"but":[171,247],"also":[172],"entry":[174],"latency.":[179],"High":[180],"content":[181],"have":[183],"shown":[184],"need":[186],"activate":[188],"both":[189,230],"P-TEFb":[190,231],"reverse":[192],"blocks.":[194],"Evaluation":[195],"mechanisms":[198],"cytokines,":[205],"disulfiram,":[206],"farnesyl":[207],"transferase":[208],"ESR1":[210],"inhibitors":[211],"highlights":[212],"how":[213],"unique":[216],"pathways":[217],"can":[218,242],"lead":[219,243],"reactivation.":[222],"Conclusions:":[223],"reactivation":[225,246,274],"requires":[229],"transcription":[233],"initiation.":[234],"Reversing":[235],"any":[236],"number":[237,251],"rate":[239],"limiting":[240],"steps":[241],"limited":[250],"cells.":[253],"This":[254],"suggests":[255],"there":[257],"will":[258],"opportunities":[261],"identify":[263],"synergies":[264],"between":[265],"different":[266],"classes":[267],"activators":[270],"design":[272],"efficient":[273],"strategies.":[275]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}